U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309614) titled 'A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma' on Nov. 25.
Brief Summary: This study tests whether an asthma medication called dupilumab can help people achieve complete asthma control (called "remission") when given earlier in their disease, before asthma becomes severe. Currently, most people with asthma only receive advanced treatments like biologics after their condition has worsened significantly and caused lung damage. This study explores whether treating high-risk patients earlier could prevent asthma attacks and lung function decline, potentially achieving remission before permanent damag...